I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 27 studies | 32% ± 14% | |
| mast cell | 15 studies | 44% ± 19% | |
| CD16-positive, CD56-dim natural killer cell, human | 14 studies | 34% ± 13% | |
| CD16-negative, CD56-bright natural killer cell, human | 14 studies | 36% ± 16% | |
| mature NK T cell | 7 studies | 24% ± 8% | |
| fibroblast | 7 studies | 30% ± 10% | |
| B cell | 6 studies | 30% ± 13% | |
| CD8-positive, alpha-beta T cell | 6 studies | 21% ± 4% | |
| mesothelial cell | 6 studies | 45% ± 22% | |
| naive B cell | 5 studies | 21% ± 6% | |
| innate lymphoid cell | 5 studies | 29% ± 12% | |
| basal cell | 5 studies | 47% ± 22% | |
| type II pneumocyte | 5 studies | 37% ± 5% | |
| pericyte | 4 studies | 34% ± 10% | |
| plasma cell | 4 studies | 37% ± 11% | |
| epithelial cell | 4 studies | 31% ± 16% | |
| lymphocyte | 4 studies | 36% ± 15% | |
| club cell | 4 studies | 34% ± 10% | |
| type I pneumocyte | 4 studies | 23% ± 3% | |
| monocyte | 3 studies | 22% ± 6% | |
| precursor B cell | 3 studies | 29% ± 6% | |
| immature B cell | 3 studies | 22% ± 5% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 21% ± 1% | |
| rod bipolar cell | 3 studies | 55% ± 24% | |
| T cell | 3 studies | 24% ± 5% | |
| respiratory goblet cell | 3 studies | 41% ± 10% | |
| gamma-delta T cell | 3 studies | 19% ± 2% | |
| goblet cell | 3 studies | 54% ± 21% | |
| mucus secreting cell | 3 studies | 29% ± 5% |
